Clinical Trial

TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium

Study acronym: TriRec
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 26, 2018 (before its estimated January 2020 completion). Its status may not reflect the trial's current state.
Summary
Reconstruction of the aortic valve using the tri-leaflet repair technique is non-inferior with regard to effective orifice area (EOA) to surgical aortic valve replacement (SAVR) with a biological prosthesis (St. Jude Trifecta GT) as gold- standard.
Trial Details
NCT Number NCT03600662
Lead Sponsor Deutsches Herzzentrum Muenchen
Collaborators: Department of Cardiovascular Surgery, German Heart Center Munich
Conditions Alternative Surgical Treatment for Aortic Valve Disease
Enrollment 128 participants
Start Date 2018-01-18
Primary Completion 2020-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2018-07-26